SEC filing · 8-K

Angiodynamics Inc: Quarterly results

AngioDynamics reported first quarter net sales of $80.9 million and narrowed its net loss amid double-digit Med Tech growth.

Filed October 8, 2026

Positive for the company

What happened

Net sales rose 6.9% year over year to $80.9 million, led by a 13.2% increase in Med Tech net sales to $39.9 million.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Angiodynamics Inc

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.